Home/Filings/4/0001144204-16-080438
4//SEC Filing

Tonix Pharmaceuticals Holding Corp. 4

Accession 0001144204-16-080438

$TNXPCIK 0001430306operating

Filed

Feb 9, 7:00 PM ET

Accepted

Feb 10, 5:40 PM ET

Size

8.2 KB

Accession

0001144204-16-080438

Insider Transaction Report

Form 4
Period: 2016-02-09
DAUGHERTY BRUCE
SEE REMARKS
Transactions
  • Award

    Stock Option

    2016-02-09+30,00030,000 total
    Exercise: $5.03Exp: 2026-02-09Common Stock (30,000 underlying)
  • Award

    Stock Option

    2016-02-09+30,00030,000 total
    Exercise: $5.03Exp: 2026-02-09Common Stock (30,000 underlying)
Footnotes (3)
  • [F1]The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months.
  • [F2]The option was granted pursuant to the Issuer's 2014 Stock Incentive Plan.
  • [F3]The option vests 1/3rd upon the date(s) that certain stock price goals are achieved. The stock price goals are such date(s) when the Issuer's common stock has an average closing sales price equal to or exceeding each of $6.00, $7.00 and $8.00 per share for 20 consecutive trading days, subject to a one year minimum service period prior to vesting.

Issuer

Tonix Pharmaceuticals Holding Corp.

CIK 0001430306

Entity typeoperating
IncorporatedNV

Related Parties

1
  • filerCIK 0001430306

Filing Metadata

Form type
4
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 5:40 PM ET
Size
8.2 KB